Healthcare provider profile · identity verified

Daniel R Conner, DO

Family Practice · WILLIAMSPORT, PA · NPI 1144670266

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	242	79
Amlodipine Besylate	Amlodipine Besylate	202	58
Omeprazole	Omeprazole	189	48
Lisinopril	Lisinopril	183	67
Levothyroxine Sodium	Levothyroxine Sodium	175	42
Potassium Chloride	Potassium Chloride	113	24
Pantoprazole Sodium	Pantoprazole Sodium	107	24
Albuterol Sulfate Hfa	Albuterol Sulfate	103	39
Losartan Potassium	Losartan Potassium	97	24
Metoprolol Succinate	Metoprolol Succinate	93	32
Eliquis	Apixaban	89	23
Gabapentin	Gabapentin	89	28
Metformin Hcl	Metformin Hcl	85	26
Jardiance	Empagliflozin	82	19
Fluticasone Propionate	Fluticasone Propionate	79	30
Rosuvastatin Calcium	Rosuvastatin Calcium	67	24
Furosemide	Furosemide	66	17
Clopidogrel	Clopidogrel Bisulfate	59	15
Sertraline Hcl	Sertraline Hcl	56	15
Trazodone Hcl	Trazodone Hcl	54	15
Tamsulosin Hcl	Tamsulosin Hcl	53	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	52	12
Simvastatin	Simvastatin	47	17
Citalopram Hbr	Citalopram Hydrobromide	46	12
Hydroxyzine Hcl	Hydroxyzine Hcl	45	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	45	suppressed
Chlorthalidone	Chlorthalidone	39	12
Quetiapine Fumarate	Quetiapine Fumarate	38	suppressed
Trulicity	Dulaglutide	37	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	36	suppressed
Carvedilol	Carvedilol	36	12
Buspirone Hcl	Buspirone Hcl	35	11
Montelukast Sodium	Montelukast Sodium	35	11
Metformin Hcl Er	Metformin Hcl	34	14
Ventolin Hfa	Albuterol Sulfate	34	13
Allopurinol	Allopurinol	32	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	32	suppressed
Breo Ellipta	Fluticasone/Vilanterol	31	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	31	suppressed
Alendronate Sodium	Alendronate Sodium	29	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	29	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	28	12
Bupropion Xl	Bupropion Hcl	26	suppressed
Duloxetine Hcl	Duloxetine Hcl	26	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	24	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Meloxicam	Meloxicam	24	suppressed
Atenolol	Atenolol	23	suppressed
Diclofenac Sodium	Diclofenac Sodium	23	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	23	suppressed
Levetiracetam	Levetiracetam	22	suppressed
Tizanidine Hcl	Tizanidine Hcl	21	suppressed
Clonidine Hcl	Clonidine Hcl	20	suppressed
Famotidine	Famotidine	20	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	19	suppressed
Spironolactone	Spironolactone	19	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	18	suppressed
Mirtazapine	Mirtazapine	17	suppressed
Naproxen	Naproxen	17	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Finasteride	Finasteride	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Olanzapine	Olanzapine	16	suppressed
Prazosin Hcl	Prazosin Hcl	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	15	suppressed
Clonazepam	Clonazepam	15	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Prednisone	Prednisone	15	12
Ibuprofen	Ibuprofen	14	suppressed
Januvia	Sitagliptin Phosphate	14	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Ozempic	Semaglutide	13	suppressed
Pravastatin Sodium	Pravastatin Sodium	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	12	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Torsemide	Torsemide	12	suppressed
Febuxostat	Febuxostat	11	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed
Sucralfate	Sucralfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error